Perrigo Company PLC Asset Resilience Ratio
Perrigo Company PLC asset resilience ratio. Perrigo Company PLC (PRGO) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Perrigo Company PLC fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Perrigo Company PLC (1998–2023)
Asset resilience ratio of Perrigo Company PLC from 1998 to 2023. This chart shows how Perrigo Company PLC's Asset Resilience Ratio has changed over time. Read PRGO total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Perrigo Company PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PRGO current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $100.00K | 0.0% |
| Total Liquid Assets | $100.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Perrigo Company PLC maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Perrigo Company PLC Industry Peers by Asset Resilience Ratio
Compare Perrigo Company PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Perrigo Company PLC Asset Resilience Ratio by Year (1998–2023)
Perrigo Company PLC asset resilience ratio by year from 1998 to 2023. The table below shows the annual Asset Resilience Ratio data for Perrigo Company PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $100.00K | $10.81 Billion | +0.00pp |
| 2022-12-31 | 0.00% | $100.00K | $11.02 Billion | 0.00pp |
| 2021-12-31 | 0.00% | $400.00K | $10.43 Billion | -0.02pp |
| 2020-12-31 | 0.02% | $2.50 Million | $11.49 Billion | -0.04pp |
| 2019-12-31 | 0.06% | $6.60 Million | $11.30 Billion | -0.03pp |
| 2018-12-31 | 0.09% | $9.40 Million | $10.98 Billion | -0.06pp |
| 2017-12-31 | 0.15% | $17.00 Million | $11.63 Billion | -0.13pp |
| 2016-12-31 | 0.28% | $38.20 Million | $13.87 Billion | +0.21pp |
| 2015-12-31 | 0.07% | $12.70 Million | $19.39 Billion | +0.02pp |
| 2014-12-31 | 0.04% | $5.90 Million | $13.88 Billion | 0.00pp |
| 2013-12-31 | 0.04% | $6.00 Million | $13.85 Billion | -0.07pp |
| 2012-12-31 | 0.11% | $5.90 Million | $5.35 Billion | +0.09pp |
| 2009-12-31 | 0.02% | $557.00K | $3.09 Billion | +0.02pp |
| 2008-12-31 | 0.00% | $3.00K | $2.54 Billion | -0.02pp |
| 2007-12-31 | 0.02% | $560.00K | $2.58 Billion | -2.53pp |
| 2006-12-31 | 2.55% | $49.11 Million | $1.93 Billion | +1.02pp |
| 2005-12-31 | 1.53% | $26.73 Million | $1.75 Billion | +0.49pp |
| 2004-12-31 | 1.04% | $17.76 Million | $1.70 Billion | -0.33pp |
| 2003-12-31 | 1.38% | $10.45 Million | $759.09 Million | -13.94pp |
| 1998-12-31 | 15.32% | $89.10 Million | $581.70 Million | -- |
About Perrigo Company PLC
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and ora… Read more